Price
Target price
€312.50
€312.50
-1.160%
-3.7
-1.160%
€300.48
06.07.26 / Tradegate
WKN: 864330 / Symbol: WST / Name: West Pharmaceutical Services / Stock / Healthcare Equipment & Supplies / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
West Pharmaceutical Services Inc. Stock
We can see a decrease in the price for West Pharmaceutical Services Inc.. Compared to yesterday it has lost -€3.700 (-1.160%).
With 19 Buy predictions and not the single Sell prediction the community is currently very high on West Pharmaceutical Services Inc..
However, we have a potential of -4.0% for West Pharmaceutical Services Inc. as the target price of 300 € is below the current price of 312.5 €.
Pros and Cons of West Pharmaceutical Services Inc. in the next few years
Pros
?
B****
?
M***** P*******
?
W********* I********* f** t** n*** y****
Cons
?
S********** s********
?
C******** o* t** e**********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of West Pharmaceutical Services Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| West Pharmaceutical Services Inc. | -1.160% | 3.864% | 17.051% | 70.432% | 36.534% | -7.677% | 3.729% |
| Haemonetics Corp. | -2.270% | -2.941% | 9.091% | - | -3.650% | - | - |
| CONMED Corp. | 0.680% | -5.769% | -1.342% | -35.526% | -16.000% | -75.902% | -74.872% |
| Penumbra Inc | 0.070% | -0.360% | 0.508% | 31.217% | 3.979% | -10.645% | 21.172% |
Comments
West Pharmaceutical Services (WST) had its "outperform" rating reaffirmed by Evercore Inc.
Show more
Ratings data for WST provided by MarketBeat
West Pharmaceutical Services (WST) was upgraded by Barclays PLC to "overweight".
Show more
Ratings data for WST provided by MarketBeat
West Pharmaceutical Services (WST) had its "outperform" rating reaffirmed by Wolfe Research.
Show more
Ratings data for WST provided by MarketBeat
